Jackie Chu, Joanne V Glinsky, Hueiming Liu, Christine Rimmer, Sharon Roberts, Federica Tamburella, Claire Lincoln, Sophia Denis, Lydia W Chen, Donna Rainey, Vivien Jørgensen, Jessica van der Lede, Charlotte C M van Laake-Geelen, Mark McDonald, Emilie J Gollan, Sue Paddison, Chris Bell, Kristine Oostra, Lot Van Roey, Marsha Ben, Keira E Tranter, Giorgio Scivoletto, Annemie I Spooren, Janneke K Stolwijk, Lisa A Harvey
There were many features of the intervention provided as part of the SCI-MT Trial that both participants and therapists valued even though the trial results indicated no therapeutic benefit. Consideration should be given to how some of these features could be better incorporated into usual care to improve patient satisfaction and engagement.
STUDY DESIGN: A qualitative study.
OBJECTIVES: To explore participants', therapists' and stakeholders' experiences and perceptions of the trial intervention provided as part of the Early and Intensive Motor Training Trial for people with Spinal Cord Injury (SCI-MT Trial). The intervention involved 12 h per week of task specific training supplemented with strength training.
SETTINGS: Fifteen spinal injury units across Europe and Australia.
METHODS: Forty semi-structured interviews were conducted including 20 with trial participants, 16 with trial therapists and 4 with stakeholders. Interview questions were framed around the Implementation Research Logic Model and the interview guide was developed by the research team. Inductive and deductive thematic analyses were done iteratively. Trustworthiness was ensured through four criteria (credibility, transferability, dependability and confirmability).
RESULTS: Three themes were identified from these interviews, (i) the trial intervention was well received by participants and therapists, (ii) there were strengths and challenges to providing the trial intervention according to its key principles, and (iii) participants, therapists and stakeholders differed in what they felt the trial needed to demonstrate to justify the future rollout of the trial intervention.
CONCLUSIONS: There were many features of the intervention provided as part of the SCI-MT Trial that both participants and therapists valued even though the trial results indicated no therapeutic benefit. Consideration should be given to how some of these features could be better incorporated into usual care to improve patient satisfaction and engagement.
CLINICAL TRIAL REGISTRATION NUMBER: ACTRN12621000091808.
UNIVERSAL TRIAL NUMBER: U1111-1264-1689.